What's new

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised
Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 66, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Nivestim, filgrastim, ...

Next Article

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, ...

Related Posts

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 69, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Orphan designation: imetelstat sodium Treatment of myelodysplastic syndromes, 27/07/2020 Positive

Orphan designation: imetelstat sodium Treatment of myel...

Apr 9, 2025  0